Connor James B. 4
4 · Prologis, Inc. · Filed Apr 30, 2026
Research Summary
AI-generated summary of this filing
Prologis (PLD) Director Connor James Receives DSUs, Converts to Shares
What Happened Connor James, a director of Prologis, received a grant of 1,695 Deferred Stock Units (DSUs) on April 28, 2026 and on the same date converted previously granted DSUs/Dividend Equivalent Units (DEUs) into common stock. The filing shows (a) an award/acquisition of 1,695 DSUs at $0.00, (b) an acquisition via exercise/conversion of 1,984 shares at $0.00, and (c) a disposition/conversion entry of 1,984.549 shares at $0.00. All transactions show $0 cash price and thus no purchase proceeds or cash sale proceeds were reported.
Key Details
- Transaction date: April 28, 2026 (reported on Form 4 filed Apr 30, 2026).
- Items reported:
- Grant/Award (A): 1,695 DSUs @ $0.00 (acquired).
- Exercise/Conversion (M): 1,984 shares @ $0.00 (acquired).
- Exercise/Conversion (M) / Disposal line: 1,984.549 shares @ $0.00 (disposed).
- Shares owned after transaction: not specified in the excerpt; the Form 4 balance (column 9) includes DSUs and DEUs — see the full filing for the exact balance.
- Filing timeliness: appears timely (transaction date Apr 28; Form 4 filed Apr 30).
- Footnotes: DSUs vest per plan rules (new DSUs vest 100% on earlier of one-year anniversary or next annual meeting and are generally deferred until Apr 28, 2029); DSUs/DEUs convert 1-for-1 into common stock, earn dividend equivalents, and have no exercise price or expiration (see F1–F3).
Context
- DSUs are long‑term, non‑cash awards that convert into shares 1-for-1 when vested/released; they are not market purchases or sales. The $0.00 price reflects conversion/settlement mechanics rather than a market trade.
- The conversion/release showing both acquisition and disposition lines reflects conversion/release activity of deferred units into shares (see footnote F2). These transactions are routine plan-related events and do not necessarily indicate a buy or sell decision in the open market.
Insider Transaction Report
Form 4
Connor James B.
Director
Transactions
- Exercise/Conversion
Common Stock
2026-04-28+1,984→ 1,984 total - Award
Deferred Stock Units-NQDC
[F1]2026-04-28+1,695→ 8,261.17 totalExercise: $0.00→ Common Stock (1,695 underlying) - Exercise/Conversion
Deferred Stock Units and Dividend Equivalent Units-NQDC
[F2]2026-04-28−1,984.549→ 6,276.618 totalExercise: $0.00→ Common Stock (1,984.549 underlying)
Holdings
- 4,234(indirect: By Trust)
Common Stock
- 323,782
Units
[F3]Exercise: $0.00→ Common Stock (323,782 underlying)
Footnotes (3)
- [F1]Deferred Stock Units (DSUs) granted April 28, 2026, which vest 100% on the earlier of the first anniversary of the grant date, or the first annual meeting of the stockholders of Prologis that occurs after the grant date, and generally, are deferred under the Prologis, Inc. Nonqualified Deferred Compensation Plan until April 28, 2029. DSUs earn dividend equivalent units (DEUs) when dividends are paid with respect to Prologis common stock and have no exercisable or expiration date. DSUs and accrued DEUs are convertible into Prologis common stock on a 1-for-1 basis. Balance in column 9 includes DSUs and DEUs.
- [F2]Conversion of Deferred Stock Units (DSUs) and Dividend Equivalent Units (DEUs) that were deferred under the Prologis, Inc. Nonqualified Deferred Compensation Plan (the NQDC Plan). Original grant terms provided for release of shares on the earlier of (a) the third anniversary of the Grant Date (May 4, 2023) or (b) the first annual meeting of the stockholders of Prologis. Shares were released on April 28, 2026. DSUs and DEUs convert into Prologis common stock upon vesting on a 1-for-1 basis and have no exercise price or expiration date.
- [F3]The units have no exercisable date or expiration date.
Signature
/s/ Tammy Colvocoresses, Attorney-in-Fact for James B. Connor|2026-04-30